Clinical Estrogen Trials in Patients with Schizophrenia

  • Jayashri Kulkarni


Luteinizing Hormone Antipsychotic Drug Brief Psychiatric Rate Scale Luteinizing Hormone Level Estradiol Valerate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Behrens S, Häfner H, De Vry J, Gattaz WF (1992) Estradiol attenuates dopamine-medicated behavior in rats. Implications for sex differences in schizophrenia. Schizophr Res 6: 114CrossRefGoogle Scholar
  2. Brambilla F, Penati G (1978) Perspectives in endocrine psychobiology. In: Brambilla F and Bridges P (ed). Perspectives in endocrine psychobiology. Witey, London, 309–422Google Scholar
  3. DiPaolo T, Payet P, Labrie F (1982) Effect of prolactin and estradiol on rat striated dopamine receptors. Life Sci 31: 2921–2929Google Scholar
  4. Ferretti C, Blengio M, Vigna I, Ghia P, Gerazzani E (1992) Effects of estradiol on the ontogenesis of striatial dopamine D1 and D2 receptor sites in male and female rats. Brain Res 571: 212–217PubMedCrossRefGoogle Scholar
  5. Fink G (1995) The psychoprotective action of estrogen is mediated by central serotonergic as well as dopaminergic mechanisms. In: Takada A and Curzon G (eds). Serotonin in the central nervous system and periphery. Elsevier Science, Amsterdam, 175–187Google Scholar
  6. Fink G, Sumner B, McQueen JK, Wilson H, Rose R (1998) Sex steriod control of mood, mental state and memory. Clin Exp Pharmacol Physiol 25: 764–765PubMedGoogle Scholar
  7. Fink G, Sumner B, Rosie R, Wilson H, McQueen J (1999) Androgen actions on central serotonin neurotransmission: relevance for mood, mental state and memory. Behav Brain Res 105: 53–68PubMedCrossRefGoogle Scholar
  8. Gordon HH, Borison RL, Diamond BI (1980) Modulation of dopamine receptor sensitivity by estrogen. Biol Psychiatry 15: 389–396PubMedGoogle Scholar
  9. Gordon JH, Perry KO (1983) Pre-and postsynaptic neurochemical alteration following estrogen-induced striatal dopamine hypo-and hypersensitivity. Brain Res Bull 10: 425–428PubMedCrossRefGoogle Scholar
  10. Häfner H (1991) The epidemiology of beginning schizophrenia. Presented at the WPA Section of Epidemiology and Community Psychiatry Symposium, June 14–16, OsloGoogle Scholar
  11. Hoskins RG (1920) Endocrine factors in dementia praecox. N Engl J Med 200: 361Google Scholar
  12. Joyce JN, Smith RL, Van Hartesveldt C (1982) Estradiol suppresses then enhances intracaudate dopamine-induced contralateral deviation. Eur J Pharm 81: 117–122Google Scholar
  13. Kraepelin E (1982) Psychiatrie, vol 3, part 2, 8th ed. Translated (1919). Dementia praecox and paraphrenia. Livingstone, EdinburghGoogle Scholar
  14. Kulkarni J, de Castella A, Riedel A, Taffe J, Fitzgerald P, Burger H (2001) Estrogen — a potential new treatment in schizophrenia. Schizophr Res 48: 137–144PubMedCrossRefGoogle Scholar
  15. Kulkarni J, Smith D, McKenzie D, Hill C, Keks N, Singh B, Copolov D (1995) Donadotrophin response to naloxone challenge in female and male psychotic patients. Biol Psychiatry 38: 701–703PubMedCrossRefGoogle Scholar
  16. Kulkarni J, de Castella A, Smith D, Taffe J, Keks N, Copolov D (1996a) A clinical trial of the effects of estrogen in acutely psychotic women. Schizoph Res 20: 247–252CrossRefGoogle Scholar
  17. Kulkarni J, Gostt K, de Castella A (1996b) The menstrual cycle in women with schizophrenia. Schizophr Res 18: 254Google Scholar
  18. Mason JW (1975) Emotion as reflected in patterns of endocrine investigation. In: Levi L (ed) Emotions: their parameters and measurement. Raven Press, New York, 143–181Google Scholar
  19. Mosselman S, Polman J, Dukema R (1996) ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett 392: 49–53PubMedCrossRefGoogle Scholar
  20. Perry KO, Diamond BI, Fields JZ, Gordon JH (1981) Hypophysectomy induced hyper-sensitivity to dopamine: antagonism by estrogen. Brain Res 226: 211–219PubMedCrossRefGoogle Scholar
  21. Sachar EJ, Mason JW, Kolmer HS, Arfess KL(1963) Psychoendocrine aspects of acute schizophrenic reactions. Psychosom Med 25: 510PubMedGoogle Scholar
  22. Seeman MV, Lang M (1990) The role of estrogens in schizophrenia gender differences. Schizophr Bull 16: 185–195PubMedGoogle Scholar
  23. Shughrue PJ, Lane MV, Merchenthaler I (1997) Comparative distribution of estrogen receptor and X and B MRNA in the rat central nervous system. J Compr Neurol 388: 507–525Google Scholar
  24. Sumner BEH, Grant DE, Rosie R, Hegele-Hartung Ch, Fritzemeier KH, Fink G (1999) Effects of tamoxifen on serotonin transporter and 5-hydroxytryptamine 2A receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement. Mol Brain Res 73: 119–128PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 2005

Authors and Affiliations

  • Jayashri Kulkarni

There are no affiliations available

Personalised recommendations